DexCom EBITDA 2010-2025 | DXCM

DexCom annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • DexCom EBITDA for the quarter ending March 31, 2025 was $0.194B, a 26.11% increase year-over-year.
  • DexCom EBITDA for the twelve months ending March 31, 2025 was $0.858B, a 1.1% increase year-over-year.
  • DexCom 2024 annual EBITDA was $0.818B, a 4.34% increase from 2023.
  • DexCom 2023 annual EBITDA was $0.784B, a 43.25% increase from 2022.
  • DexCom 2022 annual EBITDA was $0.547B, a 48.75% increase from 2021.
DexCom Annual EBITDA
(Millions of US $)
2024 $818
2023 $784
2022 $547
2021 $368
2020 $367
2019 $191
2018 $-157
2017 $-26
2016 $-49
2015 $-46
2014 $-13
2013 $-21
2012 $-48
2011 $-40
2010 $-42
2009 $-42
DexCom Quarterly EBITDA
(Millions of US $)
2025-03-31 $194
2024-12-31 $247
2024-09-30 $207
2024-06-30 $210
2024-03-31 $154
2023-12-31 $269
2023-09-30 $254
2023-06-30 $172
2023-03-31 $89
2022-12-31 $162
2022-09-30 $187
2022-06-30 $121
2022-03-31 $78
2021-12-31 $33
2021-09-30 $144
2021-06-30 $125
2021-03-31 $67
2020-12-31 $124
2020-09-30 $113
2020-06-30 $83
2020-03-31 $47
2019-12-31 $116
2019-09-30 $69
2019-06-30 $11
2019-03-31 $-5
2018-12-31 $-156
2018-09-30 $22
2018-06-30 $2
2018-03-31 $-25
2017-12-31 $16
2017-09-30 $4
2017-06-30 $-10
2017-03-31 $-37
2016-12-31 $-3
2016-09-30 $-14
2016-06-30 $-16
2016-03-31 $-16
2015-12-31 $4
2015-09-30 $-40
2015-06-30 $-1
2015-03-31 $-10
2014-12-31 $4
2014-09-30 $-3
2014-06-30 $-4
2014-03-31 $-10
2013-12-31 $0
2013-09-30 $-4
2013-06-30 $-8
2013-03-31 $-9
2012-12-31 $-6
2012-09-30 $-15
2012-06-30 $-13
2012-03-31 $-14
2011-12-31 $-11
2011-09-30 $-12
2011-06-30 $-6
2011-03-31 $-11
2010-12-31 $-9
2010-09-30 $-12
2010-06-30 $-10
2010-03-31 $-10
2009-12-31 $-9
2009-09-30 $-11
2009-06-30 $-12
2009-03-31 $-10
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $32.517B $4.033B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $195.148B 85.47
Thermo Fisher Scientific (TMO) United States $162.069B 19.60
Edwards Lifesciences (EW) United States $45.045B 29.53
IDEXX Laboratories (IDXX) United States $43.992B 50.56
Alcon (ALC) Switzerland $43.297B 29.26
IQVIA Holdings (IQV) United States $28.414B 15.91
Mettler-Toledo (MTD) United States $25.128B 29.88
STERIS (STE) Ireland $23.368B 25.74
Waters (WAT) United States $20.841B 29.41
SONOVA HOLDING (SONVY) Switzerland $17.678B 0.00
Hologic (HOLX) United States $14.436B 15.69
Sysmex ADR (SSMXY) Japan $10.859B 30.80
Penumbra (PEN) United States $9.723B 76.31
Masimo (MASI) United States $9.085B 33.51
Globus Medical (GMED) United States $8.010B 19.09
Glaukos (GKOS) United States $5.914B 0.00
Teleflex (TFX) United States $5.298B 8.75
TransMedics (TMDX) United States $4.370B 94.99
Integer Holdings (ITGR) United States $4.222B 22.12
PROCEPT BioRobotics (PRCT) United States $3.205B 0.00
LivaNova (LIVN) United Kingdom $2.515B 14.98
Nihon Kohden (NHNKY) Japan $2.346B 26.90
Veracyte (VCYT) United States $2.154B 30.23
Elekta AB (EKTAY) Sweden $1.991B 17.90
Alphatec Holdings (ATEC) United States $1.606B 0.00
Artivion (AORT) United States $1.312B 122.88
Tandem Diabetes Care (TNDM) United States $1.118B 0.00
OPKO Health (OPK) United States $1.079B 0.00
Integra LifeSciences Holdings (IART) United States $1.048B 5.57
Pulse Biosciences (PLSE) United States $1.029B 0.00
SiBone (SIBN) United States $0.787B 0.00
IRadimed (IRMD) United States $0.786B 39.87
Beta Bionics (BBNX) United States $0.586B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.571B 8.88
Mesa Laboratories (MLAB) United States $0.564B 13.22
OrthoPediatrics (KIDS) United States $0.546B 0.00
RxSight (RXST) United States $0.530B 0.00
AxoGen (AXGN) United States $0.498B 0.00
Pacific Biosciences Of California (PACB) United States $0.480B 0.00
Semler Scientific (SMLR) United States $0.451B 12.00
Delcath Systems (DCTH) United States $0.442B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.436B 0.00
AngioDynamics (ANGO) United States $0.389B 0.00
Treace Medical Concepts (TMCI) United States $0.389B 0.00
NeuroPace (NPCE) United States $0.341B 0.00
ClearPoint Neuro (CLPT) United States $0.327B 0.00
Biosig Technologies (BSGM) United States $0.284B 0.00
Alpha Tau Medical (DRTS) Israel $0.269B 0.00
908 Devices (MASS) United States $0.238B 0.00
Tactile Systems Technology (TCMD) United States $0.236B 14.27
Neuronetics (STIM) United States $0.224B 0.00
Sight Sciences (SGHT) United States $0.218B 0.00
Inogen (INGN) United States $0.201B 0.00
CVRx (CVRX) United States $0.172B 0.00
Spectral Diagnostics (EDTXF) Canada $0.171B 0.00
Rapid Micro Biosystems (RPID) United States $0.159B 0.00
LENSAR (LNSR) United States $0.155B 0.00
Accuray (ARAY) United States $0.146B 0.00
Anteris Technologies Global (AVR) Australia $0.137B 0.00
Lucid Diagnostics (LUCD) United States $0.111B 0.00
Atossa Genetics (ATOS) United States $0.110B 0.00
Monogram Orthopaedics (MGRM) United States $0.104B 0.00
Microbot Medical (MBOT) United States $0.095B 0.00
Sensus Healthcare (SRTS) United States $0.077B 46.60
EnVVeno Medical (NVNO) United States $0.070B 0.00
InspireMD (NSPR) United States $0.069B 0.00
Spectral AI (MDAI) United States $0.068B 0.00
Hyperfine (HYPR) United States $0.062B 0.00
EDAP TMS S.A (EDAP) France $0.059B 0.00
Covalon Technologies (CVALF) Canada $0.052B 21.11
Vicarious Surgical (RBOT) United States $0.045B 0.00
Precision Optics (POCI) United States $0.037B 0.00
Envoy Medical (COCH) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Baird Medical Investment Holdings (BDMD) $0.026B 0.00
Adagio Medical Holdings (ADGM) United States $0.024B 0.00
NexGel (NXGL) United States $0.020B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
WORK Medical Technology Group (WOK) China $0.010B 0.00
PAVmed (PAVM) United States $0.010B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.008B 0.00
Ekso Bionics Holdings (EKSO) United States $0.008B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
ReShape Lifesciences (RSLS) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.07